MarketPulse
N

$NUTX

2 articles found
0 positive
2 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Block & Leviton Llp

Aldeyra Therapeutics Stock Plummets 65% After FDA Rejection; Securities Fraud Investigation Launched

Aldeyra Therapeutics ($ALDX) shares crashed 65% following FDA rejection of reproxalap for dry eye disease. Law firm Block & Leviton investigates potential securities fraud.
EOSENUTXALDXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Lowey Dannenberg P.C.

Nutex Health Stock Plummets 24% After $55M Arbitration Disclosure Triggers Securities Probe

Law firm investigates $NUTX for securities violations following 24% stock drop tied to $55M arbitration claim reversal affecting nearly 19,000 disputes.
NUTXclass action lawsuitstock decline